이식형 신경자극기 시장 규모, 점유율, 동향 분석 리포트 : 제품 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Implantable Neurostimulators Market Size, Share & Trends Analysis Report By Product Type (Spinal Cord Stimulators, Deep Brain Stimulators), By Application (Epilepsy), By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

이식형 신경자극기 시장 성장과 동향

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 이식형 신경자극기 시장 규모는 2025-2030년에 CAGR 10.3%로 확대하며, 2030년에는 98억 7,000만 달러에 달할 것으로 예측됩니다.

신경질환의 발병률 증가와 이와 관련된 만성 통증 및 불편함의 발생률 증가가 시장을 주도하고 있습니다.

파킨슨병, 간질, 본태성 떨림, 만성 통증, 우울증 등 신경질환의 유병률 증가는 이식형 신경 자극기에 대한 수요 증가로 이어지며, WHO에 따르면 2020년에는 전 세계에서 약 5,000만 명이 간질로 고통받고 있습니다. 이식형 신경 자극기는 간질 발작을 제어하는 데 사용됩니다. 따라서 간질 환자 수 증가는 시장 성장을 가속할 것으로 예상됩니다.

또한 고령화 사회가 진행됨에 따라 신경 장애에 걸리기 쉬워지고 있으며, CDC에 따르면 파킨슨병(PD)은 주로 60세 이상에서 진단되며, 60세 이상의 1.0%에서 80세까지 4%가 발병할 것으로 예측되고 있습니다.

또한 새로운 기술 도입과 시장 진출기업의 신제품 채택은 예측 기간 중 시장을 촉진할 가능성이 높습니다. 예를 들어 2019년 9월 Abbott는 만성 통증 관리를 위한 Proclaim XR 무충전 SCS 시스템에 대한 미국 FDA 승인을 획득했습니다.

이식형 신경자극기 시장 보고서 하이라이트

• 척수 자극기는 만성 통증 관리에 대한 효과로 인해 2024년 매출 점유율 39.7%로 시장을 장악했습니다.
• 통증 관리 부문은 2024년 가장 큰 매출 점유율로 시장을 장악했는데, 이는 만성 통증 질환의 전 세계적 확산에 기인합니다.
• 병원 및 외래수술센터(ASC) 부문이 2024년 가장 큰 매출 점유율을 차지했습니다.
• 북미 이식형 신경 자극기 시장은 2024년 43.7%의 매출 점유율로 세계 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 이식형 신경자극기 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 이식형 신경자극기 시장 : 제품 유형 비즈니스 분석

• 제품 유형 시장 점유율, 2024년과 2030년
• 제품 유형 부문 대시보드
• 시장 규모와 예측과 동향 분석, 제품 유형별, 2018-2030년
• 척수 자극기
• 뇌심부 자극기
• 선골신경자극기
• 미주신경자극기
• 위전기 자극

제5장 이식형 신경자극기 시장 : 용도 비즈니스 분석

• 용도 시장 점유율, 2024년과 2030년
• 용도 부문 대시보드
• 시장 규모와 예측과 동향 분석, 용도별, 2018-2030년
• 통증 관리
• 간질
• 파킨슨병
• 요실금과 변실금
• 위 마비
• 기타

제6장 이식형 신경자극기 시장 : 최종 용도 비즈니스 분석

• 최종 용도 시장 점유율, 2024년과 2030년
• 최종 용도 부문 대시보드
• 시장 규모와 예측과 동향 분석, 최종 용도별, 2018-2030년
• 병원과 외래 수술 센터(ASC)
• 클리닉과 물리 치료 센터
• 기타

제7장 이식형 신경자극기 시장 : 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모와 예측 동향 분석, 2018-2030년
• 북미
  • 국가별, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 국가별, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 국가별, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 국가별, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 참가자 개요
• 기업의 시장 현황 분석
• 기업 분류
• 전략 지도제작
• 기업 개요/상장기업
  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Aleva Neurotherapeutics
  • Synapse Biomedical Inc.
  • Nevro Corp.
  • LivaNova PLC
  • NeuroPace, Inc.
  • Inspire Medical Systems, Inc.
  • Cognito Therapeutics

KSA

영문 목차

영문목차

Implantable Neurostimulators Market Growth & Trends:

The global implantable neurostimulators market size is anticipated to reach USD 9.87 billion by 2030, expanding at a CAGR of 10.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of neurological diseases and higher occurrence of associated chronic pain and discomfort are driving the market.

The rising prevalence of neurological diseases such as Parkinson's disease, epilepsy, essential tremor, chronic pain, and depression will result in increased demand for implantable neurostimulators. According to the WHO, in 2020, around 50.0 million people worldwide are suffering from epilepsy. Implanted neurostimulators are used to control epileptic seizures. Thus, increasing people suffering from epilepsy is expected to boost the market growth.

Moreover, the growing base of the aging population is more susceptible to neurological disorders, which is anticipated to be a high-impact rendering driver for this market. According to the CDC, Parkinson's disease (PD) is mostly diagnosed in individuals above the age of 60 and it is projected that PD affects 1.0% of the people over the age of 60 to 4% by age of 80.

Furthermore, the incorporation of new technologies, and the introduction of new products by market players, is likely to boost the market during the forecast period. For instance, in September 2019, Abbott received U.S. FDA approval for its Proclaim XR recharge-free SCS system for the management of chronic pain.

Implantable Neurostimulators Market Report Highlights:

• The spinal cord stimulators segment dominated the market with a revenue share of 39.7% in 2024, driven by their effectiveness in managing chronic pain conditions.
• The pain management segment dominated the market with the largest revenue share in 2024, which can be attributed to the prevalence of chronic pain disorders globally.
• The hospitals & Ambulatory Surgery Centers (ASC) segment dominated the market with the largest revenue share in 2024, driven by their role as primary providers of advanced medical treatments.
• North America implantable neurostimulators market dominated the global market with a revenue share of 43.7% in 2024, which can be attributed to the high prevalence of chronic pain conditions and neurological disorders in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product Type
  • 1.2.2. Application
  • 1.2.3. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Implantable Neurostimulators Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Implantable Neurostimulators Market: Product Type Business Analysis

• 4.1. Product Type Market Share, 2024 & 2030
• 4.2. Product Type Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Product Type, 2018 to 2030 (USD Billion)
• 4.4. Spinal Cord Stimulators
  • 4.4.1. Spinal Cord Stimulators Market, 2018 - 2030 (USD Billion)
• 4.5. Deep Brain Stimulators
  • 4.5.1. Deep Brain Stimulators Market, 2018 - 2030 (USD Billion)
• 4.6. Sacral Nerve Stimulators
  • 4.6.1. Sacral Nerve Stimulators Market, 2018 - 2030 (USD Billion)
• 4.7. Vagus Nerve Stimulators
  • 4.7.1. Vagus Nerve Stimulators Market, 2018 - 2030 (USD Billion)
• 4.8. Gastric Electrical Stimulation
  • 4.8.1. Gastric Electrical Stimulation Market, 2018 - 2030 (USD Billion)

Chapter 5. Implantable Neurostimulators Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Billion)
• 5.4. Pain Management
  • 5.4.1. Pain Management Market, 2018 - 2030 (USD Billion)
• 5.5. Epilepsy
  • 5.5.1. Epilepsy Market, 2018 - 2030 (USD Billion)
• 5.6. Parkinson's Disease
  • 5.6.1. Parkinson's Disease Market, 2018 - 2030 (USD Billion)
• 5.7. Urinary and Fecal Incontinence
  • 5.7.1. Urinary and Fecal Incontinence Market, 2018 - 2030 (USD Billion)
• 5.8. Gastroparesis
  • 5.8.1. Gastroparesis Market, 2018 - 2030 (USD Billion)
• 5.9. Others
  • 5.9.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 6. Implantable Neurostimulators Market: End Use Business Analysis

• 6.1. End Use Market Share, 2024 & 2030
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Billion)
• 6.4. Hospitals & Ambulatory Surgery Centers (ASC)
  • 6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) Market, 2018 - 2030 (USD Billion)
• 6.5. Clinics & Physiotherapy Centers
  • 6.5.1. Clinics & Physiotherapy Centers Market, 2018 - 2030 (USD Billion)
• 6.6. Others
  • 6.6.1. Others Market, 2018 - 2030 (USD Billion)

Chapter 7. Implantable Neurostimulators Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Implantable Neurostimulators Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.5. Europe
  • 7.5.1. Europe Implantable Neurostimulators Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Implantable Neurostimulators Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.7. Latin America
  • 7.7.1. Latin America Implantable Neurostimulators Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
• 7.8. MEA
  • 7.8.1. MEA Implantable Neurostimulators Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Implantable Neurostimulators Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Abbott
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Type Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Medtronic
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Type Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Boston Scientific Corporation
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Type Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Aleva Neurotherapeutics
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Type Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Synapse Biomedical Inc.
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Type Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Nevro Corp.
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Type Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. LivaNova PLC
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Type Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. NeuroPace, Inc.
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Type Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Inspire Medical Systems, Inc.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Type Benchmarking
    • 8.5.9.4. Strategic Initiatives
  • 8.5.10. Cognito Therapeutics
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial Performance
    • 8.5.10.3. Product Type Benchmarking
    • 8.5.10.4. Strategic Initiatives

관련자료